Myriad Genetics | MYGN - Gewinn Vor Steuern

Aktienkurs
3.54
Täglich Wechseln
-0.12 -3.15%
Monatlich
-31.23%
Jährlich
-20.56%
Q2 Prognose
3.51




Gewinn Vor Steuern Veränderung Datum
Agilent USD 442M 1000K 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bio-Rad Laboratories USD 929.2M 846.3M 2025-12
Bruker USD 68.2M 140.8M 2025-12
Danaher USD 1.24B 138M 2026-03
Illumina USD 157M 220M 2026-03
J&J USD 7.82B 2.86B 2026-03
Mettler Toledo International USD 329.07M 59.84M 2025-12
Myriad Genetics USD 4.6M 3.4M 2025-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Quest Diagnostics USD 334M 4M 2026-03
Quidel USD -79.5M 32.9M 2026-03
Repligen USD 19.11M 2M 2025-12
Revvity USD 91.56M 35.88M 2025-12
Standard Biotools USD -22.03M 10.87M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Veracyte USD 29.97M 10.66M 2026-03
Waters USD 264.18M 94.06M 2025-12